Skip to main content
. 2020 Jun 18;19:141. doi: 10.1186/s12944-020-01324-5

Table 2.

Association between LDL-C/HDL-C ratio concordance with TC and CIMT risk

No. of participants/cases Model 1a
(HR (95%CI))
Model 2b
(HR (95%%CI))
Model 3c
(HR (95%%CI))
Total
 Concordantly low LDL-C/HDL-C ratio and low TC 8119/923 1 1 1
 Discordantly low LDL-C/HDL-C ratio and high TC 2060/383 1.00 (0.89, 1.13) 1.04 (0.92, 1.17) 1.04 (0.92, 1.18)
 Discordantly high LDL-C/HDL-C ratio and low TC 1620/269 1.59 (1.38, 1.83) 1.55 (1.34, 1.78) 1.54 (1.33, 1.77)
 Concordantly high LDL-C/HDL-C ratio and high TC 1812/420 1.66 (1.47, 1.86) 1.65 (1.45, 1.87) 1.64 (1.45, 1.86)
Sensitivity analysis by excluding CIMT in the first 2 years
 Concordantly low LDL-C/HDL-C ratio and low TC 7915/719 1 1 1
 Discordantly low LDL-C/HDL-C ratio and high TC 2013/336 1.06 (0.93, 1.21) 1.09 (0.95, 1.24) 1.1 (0.96, 1.25)
 Discordantly high LDL-C/HDL-C ratio and low TC 1561/210 1.65 (1.41, 1.93) 1.60 (1.37, 1.89) 1.60 (1.36, 1.87)
 Concordantly high LDL-C/HDL-C ratio and high TC 1720/328 1.63 (1.42, 1.86) 1.61 (1.4, 1.85) 1.61 (1.40, 1.85)

aModel 1: adjusted for age, gender at baseline

bModel 2: adjusted for age, gender, BMI, smoking, drinking, WC, TC, TG, creatinine, lipid-lowering medications, T2DM, hypertension, and fatty liver at baseline

cModel 3: adjusted for age, gender, BMI, smoking, drinking, WC, TC, TG, creatinine, WBC, lipid-lowering medications, T2DM, hypertension, and fatty liver at baseline